Methods and compositions for treatment of ocular fibrosis

Details for Australian Patent Application No. 2010300813 (hide)

Owner Gilead Biologics, Inc.

Inventors Stalmans, Ingeborg; Van Bergen, Tine; Smith, Victoria

Agent FB Rice

Pub. Number AU-A-2010300813

PCT Pub. Number WO2011/041309

Priority 61/277,918 29.09.09 US; 61/397,456 11.06.10 US

Filing date 28 September 2010

Wipo publication date 7 April 2011

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/041309 Priority application(s): WO2011/041309

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300814-Data center network distribution system

2010300795-Internally curing cement based materials